Clinical Trial Update: ACE-inhibitors in Extracapillary Glomerulonephritis [Phase 2]

View source ↗

Summary

An update on a Phase 2 clinical trial evaluating ACE inhibitors for crescentic (extracapillary) glomerulonephritis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Crescentic Glomerulonephritis

Drugs mentioned

• ACE inhibitors

Snippet

Sponsor: Monia Lorini | Conditions: Extracapillary Glomerulonephritis | Phase 2 | Status: UNKNOWN